November 19, 2015
We are pleased to introduce the human & animal primary cell products in the Benelux. The products have research applications in a variety of life science market segments.
October 09, 2015
With his project: "Mosquitoes as bridge vectors between apes and humans: The role of skin bacterial composition" he convinced the judges of the Microbiome Project the importance of his research.
September 14, 2015
Sanbio proudly sponsored Team Pathology-DNA, who swom 2100 meters in the Singelgracht and De Dommel in Den Bosch to raise money for charity.
August 27, 2015
Our continuous efforts to improve our high standard of quality and support is part of a certified ISO9001 quality system.
July 17, 2015
Sanbio recently signed contracts with the companies EnoGene and Cellworks to distribute their products within the Benelux countries.
April 23, 2015
We are pleased to partner with Molecular Devices, whose innovative analytical solutions for cell and protein biology are enabling scientists to see more, do more, and know more, and to answer life's most important questions.
April 13, 2015
Sanbio is pleased to be able to offer the unique chemicals and biochemicals, focused on the discovery of speciality research chemicals for cancer chemoprevention, from LKT Laboratories.
April 03, 2015
Sanbio is looking for new talent to join our enthusiastic team and who have the ambition to be part of a growing international company with exciting life science products for research and diagnostics.
April 01, 2015
We are pleased to announce that One Lambda has signed an agreement with Sanbio B.V., to be the exclusive channel partner for the Life Technologies HLA product portfolio in addition to its existing One Lambda products.
January 16, 2015
RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma.
January 15, 2015
Sanbio signed an exclusive contract with ESI BIO, division of BioTime Inc. The breakthrough stem cell technologies, light the path from research to clinic in order to help our customers with their goal of treating disease.